159 related articles for article (PubMed ID: 37776848)
1. Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.
Tsai CT; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA; Chao TF
Thromb Haemost; 2024 Mar; 124(3):253-262. PubMed ID: 37776848
[TBL] [Abstract][Full Text] [Related]
2. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
3. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
Chao TF; Chiang CE; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA
Heart Rhythm; 2021 Jun; 18(6):871-877. PubMed ID: 33640447
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):681-691. PubMed ID: 37580139
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Chiang CE; Liao JN; Chen TJ; Lip GYH; Chen SA
Chest; 2020 May; 157(5):1266-1277. PubMed ID: 31809694
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation.
Lin KJ; Singer DE; Bykov K; Bessette LG; Mastrorilli JM; Cervone A; Kim DH
JAMA Netw Open; 2023 Mar; 6(3):e234086. PubMed ID: 36976562
[TBL] [Abstract][Full Text] [Related]
9. The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.
Tsai CT; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA; Chao TF
BMC Med; 2024 Mar; 22(1):113. PubMed ID: 38475752
[TBL] [Abstract][Full Text] [Related]
10. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants.
Chan YH; Lee HF; Li PR; Liu JR; Chao TF; Wu LS; Chang SH; Yeh YH; Kuo CT; See LC; Lip GYH
Cardiovasc Diabetol; 2020 May; 19(1):63. PubMed ID: 32404168
[TBL] [Abstract][Full Text] [Related]
12. Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study.
Cheng WH; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA; Chao TF
Mayo Clin Proc; 2021 Jan; 96(1):52-65. PubMed ID: 33413835
[TBL] [Abstract][Full Text] [Related]
13. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
14. Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.
Hsu JY; Liu PP; Liu AB; Lin SM; Huang HK; Loh CH
J Am Heart Assoc; 2021 Feb; 10(5):e016437. PubMed ID: 33586465
[TBL] [Abstract][Full Text] [Related]
15. Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation.
Kim D; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
Europace; 2021 Feb; 23(2):184-195. PubMed ID: 33063123
[TBL] [Abstract][Full Text] [Related]
16. Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study.
Grymonprez M; Petrovic M; De Backer TL; Ikram MA; Steurbaut S; Lahousse L
Age Ageing; 2023 Mar; 52(3):. PubMed ID: 36934339
[TBL] [Abstract][Full Text] [Related]
17. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
[TBL] [Abstract][Full Text] [Related]
18. Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years.
Tsai CT; Liao JN; Chen SJ; Jiang YR; Chen TJ; Chao TF
Eur J Clin Invest; 2021 Jun; 51(6):e13488. PubMed ID: 33420738
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
[TBL] [Abstract][Full Text] [Related]
20. Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study.
Grymonprez M; Petrovic M; De Backer TL; Steurbaut S; Lahousse L
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):55-65. PubMed ID: 36941126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]